Barely Significant
← all excerpts

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance.

Cancers (Basel) · 2022 · PMC9497102 · PMID 36139615

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.